CIP
AVNS

Convergence Investment Partners’s Avanos Medical AVNS Stock Holding History

Convergence Investment Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-36,606
Closed -$1.44M – 326
2017
Q2 		$1.44M Sell
36,606
-60,383
-62% -$2.28M 0.21% 187
2017
Q1 		$3.69M Sell
96,989
-6,110
-6% -$238K 0.52% 49
2016
Q4 		$3.81M Buy
+103,099
New +$3.68M 0.53% 48

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Convergence Investment Partners's AVNS Position: Q3 2017 in Review

Convergence Investment Partners sold out of Avanos Medical (AVNS) in Q3 2017, closing a stake of 36,606 shares — an estimated $1.44M sold.

Convergence Investment Partners first reported a position in AVNS in Q4 2016 and held it in 3 quarters. The position peaked at $3.81M in Q4 2016. 318 funds tracked by Wall St. Rank hold AVNS as of Q3 2017.

  • Convergence Investment Partners reported no remaining Avanos Medical position as of Q3 2017 after selling out during the quarter.
  • Convergence Investment Partners sold 36,606 Avanos Medical shares in Q3 2017, an estimated $1.44M.
  • Convergence Investment Partners first reported a position in Avanos Medical in Q4 2016 and held it in 3 quarters.
  • Convergence Investment Partners's Avanos Medical position peaked at $3.81M in Q4 2016.
  • 318 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2017.

Based on Convergence Investment Partners's 13F filing for Q3 2017, filed 13 Nov 2017.